Understanding the problem of inadequately staging early ovarian cancer

European Journal of Cancer

Volumn 46, Issue 5, 2010, Pages 880-884

  Timmers, P J ^a,e   Zwinderman, A H ^b   Coens, C ^c   Vergote, I ^d   Trimbos, J B ^e  

^a Maasstad Hospital   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c EORTC DATA CENTER   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Early ovarian cancer; Incomplete staging; Multicentre trials; Staging laparotomy; Surgical staging

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL HYSTERECTOMY; ADULT; ARTICLE; CANCER STAGING; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; OVARY CANCER; PERITONEAL BIOPSY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

BIOPSY; EUROPE; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77349123313     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.12.012     Document Type: Article

References (20)

1. Piver M., Barlow J., and Shashikant B. Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet Gynecol 50 (1978) 100-104
2. Young R., Decker D., Wharton J., et al. Staging laparotomy in early ovarian cancer patients. JAMA 250 (1983) 3072-3076
3. Soper J., Johnson P., Johnson V., Berchuk A., and Clarke D. Comprehensive restaging laparotomy in women with apparent early ovarian carcinoma. Obstet Gynecol 80 (1992) 950-953
4. Zanetta G., Rota S., Chiari S., et al. The accuracy of staging: an important prognostic determinator in stage I ovarian carcinoma. A multivariate analysis. Ann Oncol 9 (1998) 1097-1101
5. Trimbos J.B., Vergote I., Bolis G., et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma. European Organisation for Research and Treatment of Cancer. Adjuvant chemotherapy in ovarian neoplasm trial. J Natl Cancer Inst 95 (2003) 113-124
6. Mutch D. Surgical management of ovarian cancer. Semin Oncol 29 (2002) 3-8
7. Nickles Fader A., and Rose P. Role of surgery in ovarian carcinoma. J Clin Oncol 25 (2007) 2873-2883
8. Verleye L., Ottevanger P.B., van der Graaf W., Reed N.S., Vergote I., and on behalf of the Gynaecological Cancer Group (GCG) of the European Organisation for Research (EORTC) Treatment of Cancer. EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer 45 (2009) 517-526
9. McGowan L., Lesher L., Norris H., and Barnett M. Misstaging of ovarian cancer. Obstet Gynecol 65 (1985) 568-572
10. Le T., Adolph A., Krepart G., Lotocki R., and Heywood M. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol 85 (2002) 351-355
11. Trimbos J.B., Schueler J.A., Lent M v., Hermans J., and Fleuren G.J. Reasons for incomplete surgical staging in early ovarian carcinoma. Obstet Gynecol 65 (1985) 568-572
12. Engelen M., Kos H., Willemse P., et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 106 (2005) 589-598
13. Tingulstad S., Skjeldestad F.E., and Hagen B. The effect of centralization of primary surgery on survival in ovarian cancer patients. Obstet Gynecol 102 3 (2003) 499-505
14. Andersen E., Knudsen A., Svarrer T., et al. The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark. Gynecol Oncol 99 (2005) 552-556
15. Andersen E.S., Knudsen A., Rix P., and Johansen B. Risk of malignancy index in the preoperative evaluation of patients with adnexal masses. Gynecol Oncol 90 (2003) 109-112
16. Ulusoy S., Akbayir O., Numanoglu C., et al. The risk of malignancy index in discrimination of adnexal masses. Int J Gynaecol Obstet 96 (2007) 186-191
17. Enakpene C.A., Omigbodun A.O., Goecke T.W., Odukogbe A.T., and Beckmann M.W. Preoperative evaluation and triage of women with suspicious adnexal masses using risk of malignancy index. J Obstet Gynaecol Res 35 (2009) 131-138
18. Van Calster B., Timmerman D., Bourne T., et al. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA 125. J Natl Cancer Inst 99 22 (2007) 1706-1714
19. Ioka A., Tsukuma H., Ajiki W., and Oshima A. Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer. Cancer Sci 95 (2004) 233-237
20. Vernooij F., Heintz A.P., Coebergh J.W., et al. Specialized and high-volume care leads to better outcomes in ovarian cancer treatment in the Netherlands. Gynecol Oncol 112 (2009) 455-461